Minute Insight: iSTAR Medical Receives CE Mark For Glaucoma Device
Executive Summary
MINIject has been approved in Europe for open-angle glaucoma patients.
You may also be interested in...
Minute Insight: AbbVie Bets Big On Glaucoma Market With iSTAR Purchase Deal
The pharmaceutical company has made a bold play to expand its presence in the device space, giving iSTAR upfront cash in a deal that grants it the right to buy iSTAR for almost half a billion dollars.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
Dexcom’s G7 Expands Globally After A Long Wait
Dexcom has expanded the availability of its G7 sensor to five new markets, including the UK and Germany. FDA approval in the US has been delayed by software changes.